GlassScriptPhysician profile
Daniel J Gould
NPI 1386052967
$85,718.22
in general payments reported to CMS, 2019-2025
33 companies · $17K in 2025
The $17K reported for 2025 was more than what 97% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,939 · 2020: $1,372 · 2021: $4,233 · 2022: $6,251 · 2023: $11K · 2024: $41K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $44K · Food and Beverage: $18K · Travel and Lodging: $6,407 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $44,040.00 |
| Food and Beverage | $18,388.54 |
| Travel and Lodging | $6,407.19 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $34,351.78 | 2023-2025 | |
| Pacira Pharmaceuticals Incorporated | $15,438.78 | 2024-2025 | Exparel, Iovera, Zilretta |
| Motiva USA, LLC | $7,012.29 | 2024-2025 | |
| Sientra, INC. | $6,920.31 | 2019-2022 | |
| Tela Bio, INC. | $4,265.94 | 2022-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Polynovo North America LLC | $3,728.87 | 2023-2024 | Novosorb Btm |
| Allergan, INC. | $3,088.55 | 2019-2022 | |
| Integra Lifesciences Corporation | $1,303.76 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Musculoskeletal Transplant Foundation INC. | $1,261.14 | 2019-2020 | |
| Tei Biosciences INC | $882.11 | 2019 | |
| Tepha INC | $847.37 | 2019 | |
| Stryker Corporation | $717.30 | 2019-2023 | Spy-Phi System, Photonblade |
| Davol INC. | $674.45 | 2022-2024 | Phasix Mesh, Arista Ah Flexitip |
| Surgical Innovation Associates, INC. | $655.94 | 2022 | |
| Becton, Dickinson and Company | $651.63 | 2022-2025 | Phasix Mesh |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $602.57 | 2022-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Galderma Laboratories, L.P. | $584.39 | 2019-2025 | Dysport |
| Rti Surgical, INC | $565.57 | 2025 | |
| Mentor Worldwide LLC | $451.50 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Aroa Biosurgery Incorporated | $269.65 | 2024-2025 | |
| Bard Peripheral Vascular, INC. | $251.49 | 2021 | |
| Acera Surgical, INC. | $163.83 | 2025 | Restrata Wound Matrix |
| Medtronic, INC. | $163.76 | 2025 | Unid_pass |
| Solta Medical, A Division of Bausch Health US, LLC | $156.96 | 2021-2025 | |
| Revance Therapeutics, INC. | $150.00 | 2024 | Daxxify |
| Biocircuit Technologies INC | $144.13 | 2025 | Nerve Tape |
| Microaire Surgical Instruments LLC | $108.27 | 2023 | Pal |
| Koya Medical, INC. | $105.42 | 2025 | Dayspring, Koya Medical |
| Vertex Pharmaceuticals Incorporated | $92.10 | 2025 | |
| Derma Sciences, INC. | $43.41 | 2019 | |
| Vioptix INC | $26.46 | 2019 | |
| Conmed Corporation | $19.70 | 2019 | |
| Smith+Nephew, INC. | $18.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Gould listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.